Sorafenib paradoxically activates the RAS/RAF/ERK pathway...

  • Main
  • 2018 / 03
  • Sorafenib paradoxically activates the RAS/RAF/ERK pathway...
Clinical & Experimental Immunology 2018 / 03

Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose and time-dependent manner

Lohmeyer, Julian, Nerreter, Thomas, Dotterweich, Julia, Einsele, Hermann, Seggewiss-Bernhardt, Ruth
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical & Experimental Immunology
DOI:
10.1111/cei.13128
Date:
March, 2018
File:
PDF, 2.16 MB
english, 2018
Conversion to is in progress
Conversion to is failed